FIELD: medicine. SUBSTANCE: method involves intravenously injecting dalargin as a leuenkephalin row preparation at a dose of 1 mg before applying electrostimulation. EFFECT: prevented development of pathologic centrogenous reactions. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SURGICAL METHOD FOR TREATING THE CASES OF PRIMARY GENERALIZED EPILEPSY | 1996 |
|
RU2154417C2 |
METHOD FOR RESTORING MIMIC MUSCLE FUNCTION | 1996 |
|
RU2137460C1 |
METHOD OF TREATMENT OF DIENCEPHALIC- CATABOLIC SYNDROME | 2006 |
|
RU2330659C1 |
EMBOLIZATION METHOD FOR TREATING PATHOLOGIC BY-PASS PROCESSES IN BRAIN, DURA MATER, PIA MATER, ARACHNOIDEA ENCEPHALI AND HEAD INTEGUMENTS | 1993 |
|
RU2104055C1 |
METHOD FOR DETERMINING NEUROLOGIC DEFICIENCY OF A HAND IN THE CASES OF BRAIN HEMISPHERE INJURIES | 1999 |
|
RU2194442C2 |
METHOD FOR TREATING ANEURYSMS AND CAROTID-CAVERNOUS ANASTOMOSES OF CEREBRAL VESSELS | 1998 |
|
RU2200014C2 |
METHOD OF TREATMENT OF TRIGEMINAL NEURALGIA | 1999 |
|
RU2202349C2 |
METHOD FOR TREATING MALIGNANT BRAIN TUMORS | 2000 |
|
RU2192263C2 |
METHOD OF ANESTHESIA IN BRAIN OPERATIONS | 1998 |
|
RU2146530C1 |
EPILEPSY TREATMENT METHOD | 1994 |
|
RU2132161C1 |
Authors
Dates
1996-11-10—Published
1991-09-26—Filed